Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Expand chart
Data: Axios/Ipsos Poll; Chart: Kavya Beheraj/Axios

Vaccine hesitancy in the U.S. is showing signs of crumbling, according to the latest installment of the Axios/Ipsos Coronavirus Index.

  • Fewer adults than ever now say they won't take the shot, and in the past two weeks there has been a sharp increase in the share of parents who plan to get their younger kids vaccinated as soon as it's allowed.

The big picture: Many factors are playing a role — including the Delta variant's strength, kids' return to school and FDA approval of the first COVID-19 vaccine — but the biggest drivers appear to be the rise of mandates.

  • One in three unvaccinated Americans in the survey said FDA approval would make them likely to take the vaccine. But 43% said their boss requiring vaccinations would make them likely to do so, up from 33% a month ago.

What they're saying: "Schools, organizations, companies, governments implementing mandates are forcing people to deal with them," said Cliff Young, president of Ipsos U.S. Public Affairs. "That's what going on."

Why it matters: Ipsos pollster and senior vice president Chris Jackson notes that children younger than 12 — about 48 million people — now make up the largest group of unvaccinated people in the country.

By the numbers: 68% of parents said they either have already vaccinated their children or are likely to as soon as it's permitted for their age group. That's the highest share ever in our survey, and a 12-point spike from 56% just two weeks ago.

  • 72% of adults now say they've already taken the vaccine. Another 8% say they're likely to take it.
  • The 20% who say they're either not very likely (6%) or not at all likely (14%) comprise a new low in the survey, and down from a combined 34% in March and 23% two weeks ago.

Between the lines: Over the past two weeks, the survey found an across-the-board rise in indicators related to work or government mandates.

  • 19% said their employers are requiring all workers to get vaccinated, up from 16% two weeks ago.
  • 54% said employers are requiring all workers to wear masks in the workplace, up from 51%.
  • 22% said their employers had extended or returned to a work from home policy, up from 17%.
  • 40% also reported their state or local governments were requiring masks to be worn in public places, up from 33% two weeks ago; and another 40% said teachers or government workers in their area were being requiring to get the vaccine, up from 34%.

People are adjusting their own behaviors as well: 56% saw friends or relatives outside the home in the last week, the lowest share since April. Half of respondents said they are practicing social distancing, the highest share since early May — though only 12% said they're canceling travel plans.

  • 60% say returning to their normal, pre-coronavirus lives right now would pose a large or moderate risk — up from 53% just two weeks ago.

The intrigue: The share of Americans who say they feel hopeful right now has plummeted to 34%, from 48% in March — but those saying they feel motivated, energized, inspired or resilient has risen by at least as much.

  • That suggests that, rather than giving up, these Americans are reassessing their expectations about how quick a fix the first generation of vaccines alone can be— and resolving to do what it takes over the long haul.

Methodology: This Axios/Ipsos Poll was conducted Aug. 27-30 by Ipsos' KnowledgePanel®. This poll is based on a nationally representative probability sample of 1,071 general population adults age 18 or older.

  • The margin of sampling error is ±3.2 percentage points at the 95% confidence level, for results based on the entire sample of adults.

Go deeper

FDA approves AstraZeneca COVID drug for people with immune problems

Photo: Qilai Shen/Bloomberg via Getty Images

The Food and Drug Administration issued an emergency use authorization for an AstraZeneca COVID-19 antibody drug for people with compromised immune systems.

Why it matters: The drug, Evusheld, is the first antibody therapy authorized in the U.S. to prevent coronavirus symptoms before virus exposure.

Dec 8, 2021 - Health

Nearly all U.S. cases of Omicron are mild, CDC director says

U.S. Centers for Disease Control and Prevention Director Rochelle Walensky. Photo: Stefani Reynolds/Pool via Getty Images

Of the more than 40 known cases of the Omicron variant in the U.S., nearly all are mild, Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky said Wednesday in an interview with AP.

Why it matters: Concern has ramped up with health experts forecasting a rise in Omicron cases. Over three-quarters of U.S. patients had been vaccinated, and one-third had gotten their booster shots, according to Walensky.

Dan Primack, author of Pro Rata
Dec 8, 2021 - Health

Ex-FDA chief: COVID jabs could become as common as flu shots

Photo by Alex Edelman-Pool/Getty Images

Former FDA commissioner Stephen Hahn tells Axios that Americans may eventually require annual COVID vaccination boosters, although acknowledges that right now it's just his "best guess."

Why it matters: COVID jabs could become as routine as flu shots.